When women undergo breast imaging shortly after receiving a COVID-19 vaccine in the arm, their tests may show swollen lymph nodes in the armpit area. Radiologists say that this is usually a normal finding, and if there are no other concerns, no additional imaging tests are needed unless the lymph nodes remain swollen for more than six weeks after vaccination. The team has published an approach to help avoid delays in both vaccinations and breast cancer screening.
from Breast Cancer News -- ScienceDaily https://ift.tt/3aYJCf4
Friday, February 26, 2021
Wednesday, February 17, 2021
Proton therapy induces biologic response to attack treatment-resistant cancers
Researchers have developed a novel proton therapy technique to more specifically target cancer cells that resist other forms of treatment. The technique is called LEAP, an acronym for 'biologically enhanced particle therapy.'
from Breast Cancer News -- ScienceDaily https://ift.tt/3s4DK9O
from Breast Cancer News -- ScienceDaily https://ift.tt/3s4DK9O
Tuesday, February 16, 2021
Radioactive bone cement may be safer in treating spinal tumors
A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a new study.
from Women's Health News -- ScienceDaily https://ift.tt/2NdBuy3
from Women's Health News -- ScienceDaily https://ift.tt/2NdBuy3
Radioactive bone cement may be safer in treating spinal tumors
A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a new study.
from Women's Health News -- ScienceDaily https://ift.tt/2NdBuy3
from Women's Health News -- ScienceDaily https://ift.tt/2NdBuy3
Wednesday, February 10, 2021
Drug is promising against pancreatic and breast cancers
The drug is effective at treating pancreatic cancer and prolonging survival in mice, according to a new study. A second study shows the drug is also effective against triple-negative breast cancer, a fast-growing and hard-to-treat type of breast cancer that carries a poor prognosis. Clinical trials are set to begin in 2021.
from Breast Cancer News -- ScienceDaily visit
from Breast Cancer News -- ScienceDaily visit
Tuesday, February 9, 2021
A 'skeletal age' calculator to predict bone fracture risk
Researchers have developed a model to predict the biological age of bones that may improve the management of osteoporotic fractures.
from Women's Health News -- ScienceDaily https://ift.tt/3a1Kuir
from Women's Health News -- ScienceDaily https://ift.tt/3a1Kuir
Monday, February 8, 2021
Halt cell recycling to treat cancer
Targeting and changing autophagy, otherwise known as cell recycling, has been linked to helping control or diminish certain cancers. Now, researchers have shown that completely halting this process in a very aggressive form of breast cancer may improve outcomes for patients one day.
from Breast Cancer News -- ScienceDaily https://ift.tt/2MBXXVn
from Breast Cancer News -- ScienceDaily https://ift.tt/2MBXXVn
Study links exposure to nighttime artificial lights with elevated thyroid cancer risk
People living in regions with high levels of outdoor artificial light at night may face a higher risk of developing thyroid cancer.
from Breast Cancer News -- ScienceDaily https://ift.tt/3rwMlSf
from Breast Cancer News -- ScienceDaily https://ift.tt/3rwMlSf
Study links exposure to nighttime artificial lights with elevated thyroid cancer risk
People living in regions with high levels of outdoor artificial light at night may face a higher risk of developing thyroid cancer.
from Women's Health News -- ScienceDaily https://ift.tt/3rwMlSf
from Women's Health News -- ScienceDaily https://ift.tt/3rwMlSf
Study links exposure to nighttime artificial lights with elevated thyroid cancer risk
People living in regions with high levels of outdoor artificial light at night may face a higher risk of developing thyroid cancer.
from Women's Health News -- ScienceDaily https://ift.tt/3rwMlSf
from Women's Health News -- ScienceDaily https://ift.tt/3rwMlSf
Tuesday, February 2, 2021
Working outdoors linked to lower risk of breast cancer among older women
Working outdoors over many years is linked to a lower risk of breast cancer in women after the age of 50, finds new research.
from Breast Cancer News -- ScienceDaily https://ift.tt/2MwWJdI
from Breast Cancer News -- ScienceDaily https://ift.tt/2MwWJdI
Working outdoors linked to lower risk of breast cancer among older women
Working outdoors over many years is linked to a lower risk of breast cancer in women after the age of 50, finds new research.
from Women's Health News -- ScienceDaily https://ift.tt/2MwWJdI
from Women's Health News -- ScienceDaily https://ift.tt/2MwWJdI
Working outdoors linked to lower risk of breast cancer among older women
Working outdoors over many years is linked to a lower risk of breast cancer in women after the age of 50, finds new research.
from Women's Health News -- ScienceDaily https://ift.tt/2MwWJdI
from Women's Health News -- ScienceDaily https://ift.tt/2MwWJdI
Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
Hormone therapy can be very effective for so-called estrogen receptor-positive breast cancer. But it only works for a little more than half of women who receive the treatment. In a small study, researchers found that women whose tumors did not respond to a one-day estrogen challenge did not benefit from hormone therapy. The findings could help doctors choose treatments most likely to help their patients.
from Women's Health News -- ScienceDaily https://ift.tt/2O3t5NX
from Women's Health News -- ScienceDaily https://ift.tt/2O3t5NX
Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
Hormone therapy can be very effective for so-called estrogen receptor-positive breast cancer. But it only works for a little more than half of women who receive the treatment. In a small study, researchers found that women whose tumors did not respond to a one-day estrogen challenge did not benefit from hormone therapy. The findings could help doctors choose treatments most likely to help their patients.
from Women's Health News -- ScienceDaily https://ift.tt/2O3t5NX
from Women's Health News -- ScienceDaily https://ift.tt/2O3t5NX
Subscribe to:
Posts (Atom)